Clinical Applications of the Histoculture Drug Response Assay

Clinical Cancer Research

Volumn 1, Issue 3, 1995, Pages 305-311

  Furukaw, Toshiharu ^a   Kubota, Tetsuro ^a   Hoffman, Robert M ^b,c  

^a KEIO UNIVERSITY   (Japan)

^b Anti Cancer Inc   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; MITOMYCIN C;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; DRUG RESPONSE; DRUG SENSITIVITY; FEMALE; HISTOCULTURE DRUG RESPONSE ASSAY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH CANCER; TISSUE CULTURE;

ANTINEOPLASTIC AGENTS; CELL CULTURE; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; FLUOROURACIL; HUMAN; LIVER NEOPLASMS; MALE; MIDDLE AGE; MITOMYCIN; NEOPLASM STAGING; RECTAL NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS; SUPPORT, NON-U.S. GOV'T; SURVIVAL RATE; TUMOR CELLS, CULTURED;

EID: 0028914290     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Hoffman, R. M. In Vitro sensitivity assays in cancer: A review, analysis and prognosis. J. Clin. Lab. Anal., 5: 133-143, 1991.
2. Hoffman, R. M. In Vitro assays for chemotherapy sensitivity. Crit. Rev. Oncol. Hematol., 15: 99-111, 1993.
3. Hamburger, A. W., and Salmon, S. E. Primary bioassay of human tumor stem cells. Science (Washington DC), 197: 461-463.
4. Von Hoff, D. D. He’s not going to talk about in vitro predictive assays again, is he? J. Natl. Cancer Inst., 82: 96-101, 1990.
5. Kern, D. H., Campbell, M. A., Cochran, A. J., Burk, M. W., and Morton, D. L. Cloning of human solid tumors in soft agar. Int. J. Cancer, 30: 725-729, 1982.
6. Kern, D. H., and Wiesenthal, L. M. Highly specific prediction of antineoplastic drug resistance with an in vitro assay using suprapharmalogic drug exposure. J. Natl. Cancer Inst., 82: 582-588, 1990.
7. Weisenthal, L. M., Dill, P. L., Kurnick et al, N. B., Comparison of dye exclusion assays with a clonogenic assay in the determination of drug-induced cytotoxicity. Cancer Res., 43: 258-264, 1983.
8. Selby, P., Buick, R. N., and Tannock, I. Human tumor skin cell assay (Letter). N. Engl. J. Med., 308: 1480-1481, 1983.
9. Lawler, E. M., Miller, F. R., and Heppner, G. H. Significance of three-dimensional growth patterns of mammary tissues in collagen gel cultures. In Vitro, 19: 600-610, 1983.
10. Miller, B. E., Miller, F. R., and Heppner, G. H. Assessing tumor drug sensitivity by a new in vitro assay which preserves tumor heterogeneity and subpopulation interactions. J. Cell. Physiol., 3 (Suppl.): 105-116, 1984.
11. Miller, B. E., Miller, F. R., and Heppner, G. H. Factors affecting growth and drug sensitivity of mouse mammary tumor lines in collagen gel cultures. Cancer Res., 45: 4200-4205, 1985.
12. Furukawa, T., Kubota, T., Watanabe, M., Kase, S., Saikawa, Y., Nishibori, H., Kuo, T-H., Kodaira, S., Ishibiki, K., and Kitajima, M. Increased drug resistance of cultured human cancer cell lines in a three-dimensional cellular growth assay using collagen gel matrix. J. Surg. Oncol., 49: 86-92, 1992.
13. Freeman, A. E., and Hoffman, R. M. In vivo-like growth of human tumors in vivo. Proc. Natl. Acad. Sci. USA, 83: 2694-2698, 1986.
14. Vescio, P. H., Redfern, C. H., Nelson, T. J., Ugoretz, S., Stern, P. H., and Hoffman, R. M. In ViVo-like drug responses of human tumors growing in three-dimensional, gel-supported primary culture. Proc. Natl. Acad. Sci. USA, 84: 5029-5033, 1987.
15. Hoffman, R. M., Monosov, A. Z., Connors, K. M., Herrera, H., and Price, J. H. A general native-state method for determination of proliferation capacity of human normal and tumor tissues in vitro. Proc. Natl. Acad. Sci. USA, 86: 2013-2017, 1989.
16. Vescio, R. A., Connors, K. M., Youngkin, T., Bordin, G. M., Robb, J. A., Umbreit, J. N., and Hoffman, R. M. Cancer biology for individualizes cancer therapy: Correlation of growth fraction index in native- state histoculture with tumor grade and stage. Proc. Natl. Acad. Sci. USA, 87: 691-695, 1990.
17. Vescio, R. A., Connors, K. M., Bordin, G. M., Robb, J. A., Young- Kin, T., Umbriet, J. N., and Hoffman, R. M. The distinction of small cell and non-small cell cancer by growth in native-state histoculture. Cancer Res., 50: 6095-6099, 1990.
18. Vescio, R. A., Connors, K. M., Kubota, T., and Hoffman, R. M. Correlation of histology and drug response of human tumors grown in native-state three-dimensional histoculture and in nude mice. Proc. Natl. Acad. Sci. USA, 88: 5163-5166, 1991.
19. Li, L., Margolis, L. B., and Hoffman, R. M. Skin toxicity determined in vitro by three-dimensional, native-state histoculture. Proc. Natl. Acad. Sci. USA, 88: 1908-1912, 1991.
20. Hoffman, R. M. Three-dimensional histoculture: Origins and application in cancer research. Cancer Cells, 3: 86-92, 1991.
21. Furukawa, T., Kubota, T., Watanabe, M., Takahara, T., Yamaguchi, H., Takeuchi, T., Kodaira, S., Ishibiki, K., Kitajima, M., and Hoffman, R. M. High in vivo-in vitro correlation of drug response using sponge- gel-supported three-dimensional histoculture and the MTT end point. Int. J. Cancer, 51: 489-498, 1992.
22. Furukawa, T., Kubota, T., Watanabe, M., Kase, S., Takahara, T., Yamaguchi, H., Takeuchi, T., Teramoto, T., Ishibiki, K., Kitajima, M., and Hoffman, R. M. Chemosensitivity testing of clinical gastrointestinal cancers using histoculture and the MTT end point. Anticancer Res., 12: 1377-1382, 1992.
23. Leighton, J. A sponge matrix-method for tissue cultures. Formation of organized aggregates of cells in vitro. J. Natl. Cancer Inst., 12: 545-561, 1951.
24. Sherwin, R. P., Richters, A., Yellin, A. E., and Donavan, A. J. Histoculture of human breast cancers. Surg. Oncol., 13: 9-20, 1980.
25. Hoffman, R. M. To do tissue culture in two or three dimensions? That is the question. Stem Cells, 11: 105-111, 1993.
26. Robbins, K. T., Connors, K. M., Storniolo, A. M., Hanchett, C., and Hoffman, R. M. Sponge-gel-supported histoculture drug-response assay for head and neck cancer. Arch. Otolaryngol. Head Neck Surg., 120: 288-292, 1994.
27. Maehara, Y., Watanabe, A., Kakeji, Y., Baba, H., Kohnoe, S., and Sugimachi, K. Postgastrectomy prescription of mitomycin C and UFT for patients with stage IV gastric carcinoma. Am. J. Surg., 160: 242-244, 1990.
28. Koyama, Y., and Koyama, Y. Phase I study of a new antitumor drug, I-hexylcarbamoyl-5-fluorouracil (HCFU) administered orally: An HCFU clinical study group report. Cancer Treat. Rep., 64: 861-867, 1980.
29. Carter, S.K., and Friedman, M. Integration of chemotherapy into combined modality treatment of solid tumors. II. Large bowel carcinoma. Cancer Treat. Rev., 1: 111-129, 1974.
30. Comis, R. I., and Carter, S. K. Integration of chemotherapy into combined modality treatment of solid tumors. III. Gastric cancer. Cancer Treat. Rev., 1: 221-283, 1974.
31. Perry, M. C., Green, M. R., Mick, P., and Schein, P. Cisplatin in patients with gastric cancer: A cancer and leukemia group B phase II study. Cancer Treat. Rep., 70: 415-416, 1986.
32. DeSimone, P. A., Davalia, E., Jochimensen, P. R., and Bartolucci, A. A. High-dose cisplatin in the treatment of advanced adenocarcinoma of the colon and rectum: A southeastern cancer study group trial. Cancer Treat. Rep., 70: 1229-1230, 1986.
33. Von Hoff, D. D. Selection of cancer chemotherapy for a patient by an in vitro assay versus a clinician. J. Natl. Cancer Inst., 82: 110-116, 1990.
34. Gazdar, A. F., Steinberg, S. M., Russell, E. K., Linnoila, R. I., Oie, H. K., Ghosh, B. C., Cotelingham, J. D., Johnson, B. E., Minna, J. D., and Ihde, D. C. Correlation of in vitro drug-sensitivity testing results with response to chemotherapy and survival in extensive-stage small cell lung cancer: A prospective clinical trial. J. Natl. Cancer Inst., 82: 117-124, 1990.
35. Leone, L. A., Meitner, P. A., Myers, T. J., Grace, W. R., Gajewski, W. H., Fingert, H. J., and Rotman, B. Predictive value of the fluorescent cytoprint assay (FCA): A retrospective correlation study of in vitro chemosensitivity and individual responses to chemotherapy. Cancer Invest., 9: 491-503, 1991.